Recombinant Murine GM-CSF

<strong>Recombinant Murine GM-CSF</strong>_x000D_ <strong>Catalog number:</strong> B2017211_x000D_ <strong>Lot number:</strong> Batch Dependent_x000D_ <strong>Expiration Date:</strong> Batch dependent_x000D_ <strong>Amount:</strong> 5 µg_x000D_ <strong>Molecular Weight or Concentration:</strong> 15.1 kDa_x000D_ <strong>Supplied as:</strong> Powder_x000D_ <strong>Applications:</strong> a molecular tool for various biochemical applications_x000D_ <strong>Storage:</strong> -20°C_x000D_ <strong>Keywords:</strong> CSF-2, MGI-1GM, GM-CSF, Pluripoietin-alpha, Molgramostin, Sargramostim_x000D_ <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity &gt;18 MΩ-cm) and are filtered through 0.22 um._x000D_ _x000D_ <strong>References:</strong>_x000D_ 1: Tu F, Pan L, Wu W, Cai Y, Li J, Wang X, Lai X, Chen Z, Ye L, Wang S. Recombinant GM-CSF enhances the bactericidal ability of PMNs by increasing intracellular IL-1β and improves the prognosis of secondary Pseudomonas aeruginosa pneumonia in sepsis J Leukoc Biol. 2023 Oct 26;114(5):443-458._x000D_ 2: Wiltschke C, Nemet H, Holzinger C, Gessl A, Pernerstorfer T, Förster O, Boltz-Nitulescu G. Murine recombinant GM-CSF-driven rat bone marrow cell differentiation and factors suppressing cell proliferation Immunobiology. 1989 Jun;179(2-3):145-58._x000D_ 3: Robinson EK, Covarrubias S, Zhou S, Carpenter S. Generation and utilization of a HEK-293T murine GM-CSF expressing cell line PLoS One. 2021 Apr 9;16(4):e0249117._x000D_ 4: Zhan Y, Vega-Ramos J, Carrington EM, Villadangos JA, Lew AM, Xu Y. The inflammatory cytokine, GM-CSF, alters the developmental outcome of murine dendritic cells Eur J Immunol. 2012 Nov;42(11):2889-900._x000D_ 5: Yeapuri P, Olson KE, Lu Y, Abdelmoaty MM, Namminga KL, Markovic M, Machhi J, Mosley RL, Gendelman HE. Development of an extended half-life GM-CSF fusion protein for Parkinson's disease J Control Release. 2022 Aug;348:951-965._x000D_ 6: Corcoran LM, Metcalf D, Edwards SJ, Handman E. GM-CSF produced by recombinant vaccinia virus or in GM-CSF transgenic mice has no effect in vivo on murine cutaneous leishmaniasis J Parasitol. 1988 Oct;74(5):763-7._x000D_ 7: Evans R, Shultz LD, Dranoff G, Fuller JA, Kamdar SJ. CSF-1 regulation of Il6 gene expression by murine macrophages: a pivotal role for GM-CSF J Leukoc Biol. 1998 Dec;64(6):810-6._x000D_ 8: Gao J, Huang S, Li M, Luo R, Wang X, Takashima A. GM-CSF-surface-modified B16.F10 melanoma cell vaccine Vaccine. 2006 Jun 19;24(25):5265-8._x000D_ 9: Withoff S, Glazenburg KL, van Veen ML, Kraak MM, Hospers GA, Störkel S, de Vries EG, Wilschut J, Daemen T. Replication-defective recombinant Semliki Forest virus encoding GM-CSF as a vector system for rapid and facile generation of autologous human tumor cell vaccines Gene Ther. 2001 Oct;8(20):1515-23._x000D_ <a href="https://pubmed.ncbi.nlm.nih.gov/35877763">10: Van Dis E, Fox DM, Morrison HM, Fines DM, Babirye JP, McCann LH, Rawal S, Cox JS, Stanley SA. IFN-γ-independent control of M. tuberculosis requires CD4 T cell-derived GM-CSF and activation of HIF-1α PLoS Pathog. 2022 Jul 25;18(7):e1010721. </a>_x000D_ _x000D_ <strong>Products Related to Recombinant Murine GM-CSF can be found at</strong> <a href="https://moleculardepot.com/product-category/Proteins/"> Proteins</a>